SCIENCE NEWS Study Points to Key Genetic Driver of Severe Asthma Scientists have identified a genetic basis for determining the severity of allergic asthma in experimental models of the disease. [Press release from the Cincinnati Children’s Hospital Medical Center discussing online prepublication in Nature Immunology] Bloodstream’s ‘Band-Aids’ Bad for Lupus The blood-clotting cells called platelets are usually good guys, stanching wounds so that we don’t bleed to death. But for people with lupus, the cells are villains that exacerbate the disease, according to a new study. [Press release from ScienceNow discussing online prepublication in Science Translational Medicine] LRI-Funded Funded Study Points to Increased Risk for Lupus in Men Researchers at the University of California Los Angeles have discovered that humans-males in particular-with a variant form of toll-like receptor 7 are at increased risk of developing the autoimmune disease systemic lupus erythematosus. [Press release from the Lupus Research Institute discussing online prepublication in the Proceedings of the National Academy of Sciences U.S.A] Why Fish Oils Work Swimmingly Against Diabetes Researchers have identified the molecular mechanism that makes omega-3 fatty acids so effective in reducing chronic inflammation and insulin resistance. [Press release from the University of California, San Diego School of Medicine discussing online prepublication in Cell]
|
|
POLICY NEWS NIH Director’s Response to Stem Cell Injunction [National Institutes of Health, United States] Office of the Director, National Institutes of Health; Notice of Meeting (FR Doc. 2010-20861) [National Institutes of Health, United States] Center for Scientific Review; Notice of Closed Meetings (FR Doc. 2010-21357) [National Institutes of Health, United States] National Cancer Institute; Notice of Closed Meeting (FR Doc. 2010-21282) [National Institutes of Health, United States] National Human Genome Research Institute; Notice of Closed Meeting (FR Doc. 2010-21317) [National Institutes of Health, United States] National Human Genome Research Institute; Notice of Meetings (FR Doc. 2010-20858) [National Institutes of Health, United States] National Center for Research Resources; Notice of Closed Meeting (FR Doc. 2010-21280) [National Institutes of Health, United States] National Cancer Institute’s Best Practices for Biospecimen Resources (FR Doc. 2010-20872) [National Institutes of Health, United States] Revolutionary Genome Sequencing Technologies — The $1000 Genome (SBIR [R43/R44]) (RFA-HG-10-014) [National Institutes of Health, United States] Food and Drug Administration Clinical Trial Requirements, Regulations, Compliance, and Good Clinical Practice; Public Workshop [FR Doc. 2010-20834] [Food and Drug Administration, United States]
|
|
EVENTS (Listed by Date) Select Biosciences 7th Annual RNAi & miRNA Europe September 14-15, 2010 Dublin, Ireland Immunology & Microbiology, Genetics & Genomics, Development, Other September 18-22, 2010 Barcelona, Spain Cell Symposia: Inflammation and Disease September 26-28, 2010 Lisbon, Portugal 11th International Symposium on Dendritic Cells in Fundamental and Clinical Immunology – DC2010: Forum on Vaccine Science September 26-30, 2010 Lugano, Switzerland 5th International Conference on Gene Regulation in Lymphocyte Development October 9-14, 2010 Chania, Greece Autumn Immunology Conference 2010 November 19-22, 2010 Chicago, United States Cell Symposia: Influenza – Translating Basic Insights December 2-4, 2010 Washington, D.C., United States Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES Cell Therapy Technologist (Opexa Therapeutics) Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News. Visit here to post your career opportunities.
Have we missed an important article or publication in Immune Regulation News? Click here to submit! Comments or Suggestions? Email info@connexoncreative.com with your feedback.
|
| |
|